Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:kleinc01

Total Results:

89


Modulation of gene methylation by genistein or lycopene in breast cells [Meeting Abstract]

Leszczynska, J; King, AA; Klein, CB
ISI:000239647900272
ISSN: 0893-6692
CID: 69545

Analysis of the ability of individual isoflavones in soybean-processing by-product mixtures to reduce spontaneous mutation in mismatch-repair deficient cells [Meeting Abstract]

Mure, K; Plewa, MJ; Takeshita, T; Rossman, TG; Klein, CB
ISI:000239647900236
ISSN: 0893-6692
CID: 69544

Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk?

Snow, Elizabeth T; Sykora, Peter; Durham, Troy R; Klein, Catherine B
Arsenic is an established human carcinogen. However, there has been much controversy about the shape of the arsenic response curve, particularly at low doses. This controversy has been exacerbated by the fact that the mechanism(s) of arsenic carcinogenesis are still unclear and because there are few satisfactory animal models for arsenic-induced carcinogenesis. Recent epidemiological studies have shown that the relative risk for cancer among populations exposed to 10 muM), As induces down-regulation of DNA repair, oxidative DNA damage and apoptosis. This low dose adaptive (protective) response by a toxic agent is known as hormesis and is characteristic of many agents that induce oxidative stress. A mechanistic model for arsenic carcinogenesis based on these data would predict that the low dose risk for carcinogenesis should be sub-linear. The threshold dose where toxicity outweighs protection is hard to predict based on in vitro dose response data, but might be estimated if one could determine the form (metabolite) and concentration of arsenic responsible for changes in gene regulation in the target tissues.
PMID: 15996700
ISSN: 0041-008x
CID: 72708

Lycopene prevents spontaneous mutagenesis in mismatch repair deficient human cells by inhibiting insertions but leaving deletion mutations [Meeting Abstract]

Mure, K; Takeshita, T; Rossman, TG; Klein, CB
ISI:000225073100173
ISSN: 1055-9965
CID: 50166

Arsenic mode of action at biologically plausible low doses: What are the implications for low dose cancer risk? [Meeting Abstract]

Snow, ET; Sykora, P; Durham, TR; Klein, CB
ISI:000222348900115
ISSN: 0041-008x
CID: 46526

Effects of soybean processing by-product on spontaneous mutation in mismatch-repair deficient cells [Meeting Abstract]

Mure, K; Plewa, MJ; Takeshita, T; Rossman, TG; Klein, CB
ISI:000223758700128
ISSN: 0893-6692
CID: 46885

Mechanisms of inhibition of X-ray-induced mutations in Chinese hamster G12 cells by antioxidants [Meeting Abstract]

Leszczynska, J; Lasano, S; Klein, CB
ISI:000223758700108
ISSN: 0893-6692
CID: 46884

Lycopene prevents spontaneous mutagenesis in mismatch repair deficient human cells mainly by inhibiting point mutations [Meeting Abstract]

Mure, K; Takeshita, T; Rossman, TG; Klein, CB
ISI:000187153300126
ISSN: 1055-9965
CID: 55374

Can dietary antioxidants prevent deletion mutations? [Meeting Abstract]

Klein, CB; Mure, K; Leszczynska, J; Matz, J; King, A; Rossman, TG
ISI:000187153300274
ISSN: 1055-9965
CID: 55378

Chromate-induced epimutations in mammalian cells

Klein, Catherine B; Su, Lin; Bowser, Darlene; Leszczynska, Joanna
Epigenetic gene silencing by aberrant DNA methylation of gene promoter regions is a nonmutagenic but heritable epigenetic mechanism that may mistakenly cause the silencing of important cancer-related tumor suppressor genes. Using a transgenic, V79-derived, mammalian cell line (G12) that contains a bacterial gpt reporter gene in its DNA, we can study carcinogen-induced gene inactivation by mutagenic as well as epigenetic DNA methylation mechanisms. Whereas numerous carcinogens have previously been shown to be mutagenic in these cells, a few carcinogens, including nickel, diethylstilbestrol, and X-rays, are also capable of silencing the G12 cell gpt transgene by aberrant DNA methylation. Here we report for the first time that carcinogenic potassium chromate salts can also induce aberrant DNA methylation in this system. In contrast insoluble barium chromate produced significant level of mutations in these cells but did not cause DNA methylation changes associated with transgene expression
PMCID:1241236
PMID: 12426123
ISSN: 0091-6765
CID: 39564